| Sources | Names Used |
|---|---|
| CCLE, GDSC1000, FIMM | Nilotinib |
| CTRPv2 | nilotinib |
| PharmacoGx | Nilotinib |
| Database | Identifier |
|---|---|
| Smiles: | CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5 |
| Inchikey: | HHZIURLSWUIHRB-UHFFFAOYSA-N |
| Pubchem: | 644241 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TBXA2R | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | MLC1 | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-10 |
| mRNA | TLX1 | CCLE | pan-cancer | AAC | 0.3 | 2e-10 |
| mRNA | YES1 | GDSC1000 | pan-cancer | AAC | 0.31 | 2e-10 |
| mRNA | RHAG | CCLE | pan-cancer | AAC | 0.31 | 2e-10 |
| mRNA | CA2 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | MYO16 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | TSPO2 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-10 |
| mRNA | CLEC11A | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-10 |
| mRNA | NFE2 | CCLE | pan-cancer | AAC | 0.32 | 2e-10 |
